Clinical Trial Update: Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of decitabine and bortezomib in adults with various subtypes of acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with 11q23 Rearrangement
• Acute Myeloid Leukemia with Inv
• Untreated Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 | Status: COMPLETED